PMC:7519301 / 5576-5978 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T50","span":{"begin":8,"end":16},"obj":"Disease"},{"id":"T51","span":{"begin":8,"end":12},"obj":"Disease"},{"id":"T52","span":{"begin":193,"end":201},"obj":"Disease"},{"id":"T53","span":{"begin":193,"end":197},"obj":"Disease"},{"id":"T54","span":{"begin":307,"end":315},"obj":"Disease"},{"id":"T55","span":{"begin":307,"end":311},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"mondo_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A51","pred":"mondo_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A52","pred":"mondo_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A53","pred":"mondo_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A54","pred":"mondo_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A55","pred":"mondo_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"lity of SARS-CoV-2 between humans, with a basic reproduction number R0 estimated to be 2.2 (95% CI, 1.4 to 3.9) in Wuhan, China (13), we wanted to investigate evidence of further adaptation of SARS-CoV-2 to its host, as adaptive processes could interfere with vaccine efficacy.\nDeveloping a vaccine against SARS-CoV-2 is a high priority for preventing and mitigating future waves of the pandemic (14). "}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T62","span":{"begin":27,"end":33},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T63","span":{"begin":40,"end":41},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T64","span":{"begin":289,"end":290},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T65","span":{"begin":321,"end":322},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"lity of SARS-CoV-2 between humans, with a basic reproduction number R0 estimated to be 2.2 (95% CI, 1.4 to 3.9) in Wuhan, China (13), we wanted to investigate evidence of further adaptation of SARS-CoV-2 to its host, as adaptive processes could interfere with vaccine efficacy.\nDeveloping a vaccine against SARS-CoV-2 is a high priority for preventing and mitigating future waves of the pandemic (14). "}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"128","span":{"begin":8,"end":18},"obj":"Species"},{"id":"129","span":{"begin":27,"end":33},"obj":"Species"},{"id":"130","span":{"begin":193,"end":203},"obj":"Species"},{"id":"143","span":{"begin":307,"end":317},"obj":"Species"}],"attributes":[{"id":"A128","pred":"tao:has_database_id","subj":"128","obj":"Tax:2697049"},{"id":"A129","pred":"tao:has_database_id","subj":"129","obj":"Tax:9606"},{"id":"A130","pred":"tao:has_database_id","subj":"130","obj":"Tax:2697049"},{"id":"A143","pred":"tao:has_database_id","subj":"143","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"lity of SARS-CoV-2 between humans, with a basic reproduction number R0 estimated to be 2.2 (95% CI, 1.4 to 3.9) in Wuhan, China (13), we wanted to investigate evidence of further adaptation of SARS-CoV-2 to its host, as adaptive processes could interfere with vaccine efficacy.\nDeveloping a vaccine against SARS-CoV-2 is a high priority for preventing and mitigating future waves of the pandemic (14). "}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":48,"end":60},"obj":"http://purl.obolibrary.org/obo/GO_0000003"}],"text":"lity of SARS-CoV-2 between humans, with a basic reproduction number R0 estimated to be 2.2 (95% CI, 1.4 to 3.9) in Wuhan, China (13), we wanted to investigate evidence of further adaptation of SARS-CoV-2 to its host, as adaptive processes could interfere with vaccine efficacy.\nDeveloping a vaccine against SARS-CoV-2 is a high priority for preventing and mitigating future waves of the pandemic (14). "}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T39","span":{"begin":278,"end":401},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"lity of SARS-CoV-2 between humans, with a basic reproduction number R0 estimated to be 2.2 (95% CI, 1.4 to 3.9) in Wuhan, China (13), we wanted to investigate evidence of further adaptation of SARS-CoV-2 to its host, as adaptive processes could interfere with vaccine efficacy.\nDeveloping a vaccine against SARS-CoV-2 is a high priority for preventing and mitigating future waves of the pandemic (14). "}